Cytek Biosciences, Inc.CTKBNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank17
Studio
Year-over-Year Change

Return on equity

Percentile
P17
Within normal range
vs 3Y Ago
-32.1x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025-19.47%-1179.9%
2024-1.52%+50.8%
2023-3.09%-610.3%
20220.61%-18.2%
20210.74%+100.6%
2020-121.11%-400.1%
201940.35%-